18F-TPP

DRUG2 trials

Sponsors

Massachusetts General Hospital, Yale University

Conditions

Arrhythmias, CardiacMembrane Potential Mapping

Phase 1

Membrane Potential Mapping with18F-TPP

RecruitingNCT07506616

Yale UniversityMembrane Potential Mapping

Start: 2026-08-01End: 2033-08-01Target: 24Updated: 2026-08-31

Phase 2

Evaluation of PET/MR in Patients Selected for Ablation Therapy

Active, not recruitingNCT03265431

Massachusetts General HospitalArrhythmias, Cardiac

Start: 2017-07-14End: 2027-06-30Updated: 2024-01-30

Related Papers

In vivo quantitative mapping of human mitochondrial cardiac membrane potential: a feasibility study.

2020-07-2717 citations